Great news...in October of 2021 when its maybe approved.
“Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.”
Then we learn
“The best news is that most of our patients have already been discharged, which is great. We’ve only had two patients perish,” said Kathleen Mullane, the University of Chicago infectious disease specialist overseeing the remdesivir studies for the hospital. “
Incredibly, the phrase “nearly all” is assumed to mean the same thing as “most”.
But the market doesn’t move based on news articles, it moves based on someone at the hospital telling someone at a hedge fund something that no one else knows. So despite the shaky statnews.com article, I would bet the drug is actually working very well.